Karbian, Netanel
Abutbul, Avraham
el-Amore, Raja
Eliaz, Ran
Beeri, Ronen http://orcid.org/0000-0002-8014-0702
Reicher, Barak
Mevorach, Dror
Article History
Received: 5 March 2020
Revised: 1 June 2020
Accepted: 12 June 2020
First Online: 15 July 2020
Conflict of interest
: The authors declare that they have no conflict of interest. B. Reicher is an employee of Enlivex Therapeutics Ltd.; D. Mevorach is a consultant and CMO of Enlivex Therapeutics Ltd.